Australia issues guidance on requirements for devices register
This article was originally published in Clinica
Executive Summary
The Australian Therapeutic Goods Administration (TGA) has issued its fourth medical devices guidance document aimed at explaining the new regulatory system for medical devices in Australia that commenced in October 2002 (see Clinica No 1028, p 12). Entitled the "clinical evidence requirements for inclusion of medical devices in the Australian register of therapeutic goods", the document describes the mechanics for demonstrating compliance with the essential principles, defined for each class of medical device.
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.